
DoH, Sanofi partner to accelerate development of new global vaccines in Abu Dhabi
19 June 2025 16:08
BOSTON (WAM)The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of Understanding (MoU) with Sanofi, a research and development-driven, AI-powered healthcare biopharma company at the BIO International Convention 2025, in Boston, USA.The collaboration will leverage the Emirate's health-tech ecosystem and advanced research infrastructure to drive the development of new global vaccines and strengthen regional capabilities in vaccine manufacturing.In the presence of Dr. Noura Khamis Al Ghaithi, Under-Secretary of the Department of Health – Abu Dhabi, and Laurie Gery, Global Head of Business Development, Vaccines at Sanofi, the agreement was signed during the BIO International Convention in Boston, USA, by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Baptiste de Clarens, General Manager Greater Gulf, Vaccines at Sanofi.Dr. Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at the DoH, said. 'DoH is partnering with Sanofi to expedite the development of new global vaccines. This initiative aims to shorten the timeline from early research to public availability by utilising advanced technologies, real-time data analysis, and conducting parallel clinical trial phases. By combining Sanofi's global scientific expertise with Abu Dhabi's state-of-the-art infrastructure, we set new benchmarks for resilience, innovation and international partnerships. Abu Dhabi offers a globally connected, purpose-driven environment for leading research, and together we will drive a transformative change that will safeguard the health and well-being of our community while contributing to global health security.'Both entities will work together to streamline regulatory processes, enhance manufacturing preparedness, and promote knowledge sharing between local and international experts. This partnership reflects Abu Dhabi's strategic goal to establish itself as a leading centre for bio- and pharmaceutical innovation and underscores the emirate's commitment to advancing proactive, technology-driven healthcare solutions.Baptiste de Clarens, General Manager Greater Gulf, Vaccines, Sanofi, said, 'The Memorandum of Understanding signed with the Department of Health – Abu Dhabi marks an encouraging step towards advancing global health security while reflecting our shared interest in addressing global health challenges through scientific partnership. This agreement allows us to examine how Sanofi's experience in vaccine development could complement Abu Dhabi's growing R&D ecosystem. Through this initial framework, we look forward to exploring opportunities for public-private collaboration in healthcare innovation.'
In addition, both the Department and Sanofi will advance clinical research and development planning, optimise resource allocation and establish the foundational terms for funding and access. These efforts are designed to enhance healthcare resilience and sustainability across Abu Dhabi's healthcare sector and beyond, expanding access to quality care for patients locally and globally.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
an hour ago
- Zawya
Burjeel Holdings' JV Alkalma launches regional mental health platform with four premier centers in the UAE and Saudi Arabia
Abu Dhabi: In a strategic move to enhance access to mental health services across the region, Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, has launched four specialist mental health centers under its mental health and wellbeing platform, Alkalma, through the integration of Aspris Healthcare facilities. The centers, located in Dubai's City Walk and Dubai Healthcare City, Abu Dhabi's Al Bateen, and Riyadh's King Abdullah Financial District, are recognized for delivering personalized, adaptable mental healthcare across a wide spectrum of psychological needs. These newly integrated centers deliver personalized care through a range of therapy formats, including individual, group, and family sessions, now aligned with Alkalma's mission to build a value-driven mental healthcare ecosystem rooted in prevention, accessibility, and overall wellbeing. Together, the four centers offer a combined annual capacity of approximately 90,000 consultations. Although mental health conditions affect up to one in five individuals annually, they account for less than 5% of total health spending across the region. This underinvestment is compounded by a persistent shortage of clinical professionals and limited access to integrated networks, highlighting a critical gap that Alkalma is designed to address. This launch marks the first phase of a multi-year expansion strategy. By establishing a presence in major urban markets and aligning operations with Keralty's globally validated, value-based care models, Alkalma is laying the foundation for a scalable platform positioned to meet rising demand and deliver measurable health and economic outcomes. John Sunil, Chief Executive Officer of Burjeel Holdings, said: 'Integrating these centers into our ecosystem marks a pivotal step in realizing our vision for a regional mental health platform rooted in Alkalma's values of clinical excellence and inclusivity. It enables us to expand access to high-quality care while accelerating the delivery of outcomes that matter to patients and health systems alike.' Alkalma was launched as a strategic joint venture between Burjeel Holdings and Colombia-based healthcare leader Keralty, a global organization with nearly five decades of experience in value-based care. As a founding partner, Keralty brings deep expertise in delivering integrated mental health and primary care services across nine countries, including the U.S., supporting over 500,000 individuals globally in behavioral health. Dr. Emilio Herrera, CEO of Alkalma, said: 'At Alkalma, we believe a healthcare system is defined by how it supports those most in need. There is no health without mental health. Establishing our presence in the UAE and Saudi Arabia reflects our commitment to advancing national priorities and bringing the best scientific evidence, the highest quality of care, to serve the community. This is only the beginning.' Shorooq, a leading regional investment manager, facilitated the strategic integration of Aspris Healthcare facilities. Mahmoud Adi, Founding Partner at Shorooq, said: 'We are proud to see these facilities become foundational to a regionally integrated mental health ecosystem. We believe private equity can be a transformative force in sectors that touch people's lives.' In the coming months, Alkalma will fully integrate these centers under a unified brand, expand clinical capacity, and launch a digital mental-health platform to reach under-served populations. Further centers in new communities across the UAE and Saudi Arabia are under review as part of the JV's regional scale-up plan. Alkalma is positioned to play a defining role in shaping the region's next-generation mental health ecosystem, delivering value across patients, systems and stakeholders.


Al Etihad
13 hours ago
- Al Etihad
DoH, ADPHC launch Personalised Weight Management Programme, first of its kind in Middle East
19 June 2025 21:08 ABU DHABI (ALETIHAD)The Department of Health – Abu Dhabi (DoH) and Abu Dhabi Public Health Centre (ADPHC) have launched a new Personalised Weight Management Programme, integrating digital monitoring, a unique reimbursement model, and tailored clinical programme, which is the first-of-its-kind in the Middle East, promotes sustainable weight management and active living to significantly reduce the risks of chronic diseases such as type 2 diabetes, heart disease, and certain cancers, ultimately enhancing overall quality of life and health to eligible Thiqa members aged 18 and above who are clinically identified as overweight or obese, the programme features an innovative reimbursement model designed to encourage sustained engagement, accountability, and continuous active Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Our focus is on health – not just weight. This programme supports our vision for an active, health-conscious community, empowering individuals through personalised and science-driven solutions. Weight management requires tailored solutions, not a one-size-fits-all approach, and this programme ensures each participant receives precisely what they need to succeed.'The programme provides eligible individuals with a comprehensive, personalised 360-degree health plan that includes early screening, behavioural health support, clinical interventions if medically indicated, and ongoing long-term support to ensure sustainable plans could include early screening with initial health assessments, including BMI checks and metabolic evaluations, to proactively identify risks. The programme begins with personalised behavioural and lifestyle support, featuring an initial 16-week plan, extendable beyond a year, to offer tailored behavioural, lifestyle, and medical support based on each participant's includes individual coaching, nutritional and physical activity guidance, and regular follow-ups, with progress tracked via the Sahatna digital health app, clinical interventions (if medically indicated) with access to medications, under medical supervision ensuring safe and effective care and long-term support with structured follow-up plans with ongoing nutritional guidance, regular monitoring of health indicators and activity, and clear, medically supervised strategies for safely transitioning individuals off clinical treatments to maintain sustainable Dhabi's Sahatna app serves as the dedicated digital health platform, empowering participants, in collaboration with healthcare professionals, to track comprehensive health indicators beyond weight, including physical activity, heart health, sleep, and stress levels, to foster lasting positive Rashid Obaid Al Suwaidi, Director General of ADPHC, said: 'We know that even moderate weight loss and modest increases in physical activity significantly lower chronic disease risk. Traditionally, healthcare systems have lacked clear pathways for doctors to support patients in becoming physically active or to effectively link them with supportive services. Our programme directly addresses this gap by providing structured guidance, personalised activity plans, and continuous monitoring support through digital tools and clinical oversight - empowering our community to proactively manage their health and enhance their quality of life.'Eligible Thiqa members can begin their journey by booking an initial consultation at their local primary care centre, where a dedicated healthcare provider will guide them through every step of their personalised health plan. All participants, irrespective of past experiences or challenges, are encouraged to take this important first step toward improved weight management and long-term health. This initiative underscores Abu Dhabi's ongoing commitment to personalised, preventive health solutions that improve individual well-being and community health. Source: Aletihad - Abu Dhabi


Zawya
18 hours ago
- Zawya
DoH, Sanofi partner to accelerate development of new global vaccines in Abu Dhabi
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of Understanding (MoU) with Sanofi, a research and development-driven, AI-powered healthcare biopharma company at the BIO International Convention 2025, in Boston, USA. The collaboration will leverage the Emirate's health-tech ecosystem and advanced research infrastructure to drive the development of new global vaccines and strengthen regional capabilities in vaccine manufacturing. In the presence of Dr. Noura Khamis Al Ghaithi, Under-Secretary of the Department of Health – Abu Dhabi, and Laurie Gery, Global Head of Business Development, Vaccines at Sanofi, the agreement was signed during the BIO International Convention in Boston, USA, by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Baptiste de Clarens, General Manager Greater Gulf, Vaccines at Sanofi. Dr. Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at the DoH, said. 'DoH is partnering with Sanofi to expedite the development of new global vaccines. This initiative aims to shorten the timeline from early research to public availability by utilising advanced technologies, real-time data analysis, and conducting parallel clinical trial phases. By combining Sanofi's global scientific expertise with Abu Dhabi's state-of-the-art infrastructure, we set new benchmarks for resilience, innovation and international partnerships. Abu Dhabi offers a globally connected, purpose-driven environment for leading research, and together we will drive a transformative change that will safeguard the health and well-being of our community while contributing to global health security.' Both entities will work together to streamline regulatory processes, enhance manufacturing preparedness, and promote knowledge sharing between local and international experts. This partnership reflects Abu Dhabi's strategic goal to establish itself as a leading centre for bio- and pharmaceutical innovation and underscores the emirate's commitment to advancing proactive, technology-driven healthcare solutions. Baptiste de Clarens, General Manager Greater Gulf, Vaccines, Sanofi, said, 'The Memorandum of Understanding signed with the Department of Health – Abu Dhabi marks an encouraging step towards advancing global health security while reflecting our shared interest in addressing global health challenges through scientific partnership. This agreement allows us to examine how Sanofi's experience in vaccine development could complement Abu Dhabi's growing R&D ecosystem. Through this initial framework, we look forward to exploring opportunities for public-private collaboration in healthcare innovation.' In addition, both the Department and Sanofi will advance clinical research and development planning, optimise resource allocation and establish the foundational terms for funding and access. These efforts are designed to enhance healthcare resilience and sustainability across Abu Dhabi's healthcare sector and beyond, expanding access to quality care for patients locally and globally.